The 'Roid' to Recovery? REMAP-CAP @ St Emlyn's • St Emlyn's
REMAP-CAP – The Bottom Line
REMAP-CAP – The Bottom Line
remap-cap (@remap_cap) / X
REMAP-CAP Trial
Full article: Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19
Webinar | REMAP-CAP and Why we need Platform Trials in a Pandemic! | Join our Webinar live: REMAP-CAP and Why we need Platform Trials in a Pandemic! | By The Global Health
NHMRC Clinical Trial Centre | Improving Health Outcomes
Statement from the REMAP-CAP trial on blood thinners in COVID-19 patients | Imperial News | Imperial College London
REMAP-CAP • Coronavirus
May 15, 2020: Optimized Learning While Doing: The REMAP-CAP Adaptive Platform Trial (Derek Angus, MD, MPH) - Rethinking Clinical Trials
Media — REMAP-CAP Trial
REMAP-CAP – The Bottom Line
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design.
REMAP-CAP: delivering research in the pandemic – De Intensivist
Homepage - REMAPCAP
REMAP-CAP awarded Critical Care Team of the Year at The BMJ Awards 2021 | Imperial News | Imperial College London
Site education — REMAP-CAP Trial
Partners — REMAP-CAP Trial
remap-cap (@remap_cap) / X
Site education — REMAP-CAP Trial
REMAP－CAP 紹介 – REMAP-CAP Japan
Media — REMAP-CAP Trial
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia: REMAP-CAP | DREEAM
REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19 | tctmd.com
